XML 40 R24.htm IDEA: XBRL DOCUMENT v3.3.1.900
Share-Based Compensation
12 Months Ended
Jan. 03, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
Share-Based Compensation

The Company maintains several equity plans (the “Equity Plans”) which collectively provide or provided for the grant of stock options, restricted shares, tandem stock appreciation rights, restricted share units and performance shares to certain officers, other key employees, non-employee directors and consultants. The Company has not granted any tandem stock appreciation rights. During 2010, the Company implemented the 2010 Omnibus Award Plan (as amended, the “2010 Plan”) for the issuance of equity awards as described above. In June 2015, the 2010 Plan was amended with shareholder approval, to increase the number of shares of common stock available for issuance under the plan by 20,000. All equity grants during 2015 and 2014 were issued from the 2010 Plan and it is currently the only equity plan from which future equity awards may be granted. As of January 3, 2016, there were approximately 41,564 shares of common stock available for future grants under the 2010 Plan. During the periods presented in the consolidated financial statements, the Company settled all exercises of stock options and vesting of restricted shares, including performance shares, with treasury shares.

Stock Options

The Company’s current outstanding stock options have maximum contractual terms of ten years and vest ratably over three years or cliff vest after three years. The exercise price of options granted is equal to the market price of the Company’s common stock on the date of grant. The fair value of stock options on the date of grant is calculated using the Black-Scholes Model. The aggregate intrinsic value of an option is the amount by which the fair value of the underlying stock exceeds its exercise price.

The following table summarizes stock option activity during 2015:
 
Number of Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life in Years
 
Aggregate
Intrinsic
Value
Outstanding at December 28, 2014
19,568

 
$
6.96

 
 
 
 
Granted
4,947

 
9.85

 
 
 
 
Exercised
(6,637
)
 
6.16

 
 
 
 
Forfeited and/or expired
(1,037
)
 
13.44

 
 
 
 
Outstanding at January 3, 2016
16,841

 
$
7.73

 
7.6
 
$
51,792

Vested or expected to vest at January 3, 2016
16,719

 
$
7.72

 
7.5
 
$
51,588

Exercisable at January 3, 2016
8,323

 
$
6.33

 
6.0
 
$
37,559



The total intrinsic value of options exercised during 2015, 2014 and 2013 was $30,116, $13,948 and $28,038, respectively. The weighted average grant date fair value of stock options granted during 2015, 2014 and 2013 was $2.27, $2.34 and $2.72, respectively.

The weighted average grant date fair value of stock options was determined using the following assumptions:
 
2015
 
2014
 
2013
Risk-free interest rate
1.76
%
 
1.97
%
 
1.60
%
Expected option life in years
5.62

 
6.35

 
5.62

Expected volatility
29.2
%
 
35.4
%
 
45.6
%
Expected dividend yield
2.23
%
 
2.43
%
 
2.52
%


The risk-free interest rate represents the U.S. Treasury zero-coupon bond yield correlating to the expected life of the stock options granted. The expected option life represents the period of time that the stock options granted are expected to be outstanding based on historical exercise trends for similar grants. The expected volatility is based on the historical market price volatility of our industry peer group. The expected dividend yield represents the Company’s annualized average yield for regular quarterly dividends declared prior to the respective stock option grant dates.

The Black-Scholes Model has limitations on its effectiveness including that it was developed for use in estimating the fair value of traded options which have no vesting restrictions and are fully transferable and that the model requires the use of highly subjective assumptions including expected stock price volatility. Employee stock option awards have characteristics significantly different from those of traded options and changes in the subjective input assumptions can materially affect the fair value estimates.

Restricted Shares

The Company grants RSAs and RSUs, which primarily cliff vest after one to three years. For the purposes of our disclosures, the term “Restricted Shares” applies to RSAs and RSUs collectively unless otherwise noted. The fair value of Restricted Shares granted is determined using the average of the high and low trading prices of our common stock on the date of grant.

The following table summarizes activity of Restricted Shares during 2015:
 
Number of Restricted Shares
 
Weighted
Average
Grant Date Fair Value
Non-vested at December 28, 2014
2,443

 
$
6.80

Granted
512

 
10.09

Vested
(951
)
 
5.39

Forfeited
(205
)
 
7.64

Non-vested at January 3, 2016
1,799

 
$
8.32



The total fair value of Restricted Shares that vested in 2015, 2014 and 2013 was $10,188, $5,251 and $2,275, respectively.

Performance Shares

The Company grants performance-based awards to certain officers and key employees. The vesting of these awards is contingent upon meeting one or more defined operational goals (a performance condition) or common stock share prices (a market condition). The quantity of shares awarded ranges from 0% to 200% of “Target,” as defined in the award agreement as the midpoint number of shares, based on the level of achievement of the performance and market conditions.

The fair values of the performance condition awards granted in 2015, 2014 and 2013 were determined using the average of the high and low trading prices of our common stock on the date of grant. Share-based compensation expense recorded for performance condition awards is reevaluated at each reporting period based on the probability of the achievement of the goal.

The fair value of market condition awards granted in 2015 was estimated using the Monte Carlo simulation model. There were no market condition awards granted during 2014 or 2013. The Monte Carlo simulation model utilizes multiple input variables to estimate the probability that the market conditions will be achieved and is applied to the average of the high and low trading prices of our common stock on the date of grant.

The input variables are noted in the table below:
 
2015
Risk-free interest rate
1.00
%
Expected life in years
3.00

Expected volatility
25.6
%
Expected dividend yield (a)
0.00
%
_______________

(a)
The Monte Carlo method assumes a reinvestment of dividends.

Share-based compensation expense is recorded ratably for market condition awards during the requisite service period and is not reversed, except for forfeitures, at the vesting date regardless of whether the market condition is met.

The following table summarizes activity of performance shares at Target during 2015:
 
Performance Condition Awards
 
Market Condition Awards
 
Shares
 
Weighted
Average
Grant Date Fair Value
 
Shares
 
Weighted
Average
Grant Date Fair Value
Non-vested at December 28, 2014
933

 
$
8.81

 
668

 
$
6.04

Granted
172

 
11.15

 
112

 
17.08

Dividend equivalent units issued (a)
20

 

 
8

 

Vested (b)
(104
)
 
8.56

 
(664
)
 
6.05

Forfeited
(104
)
 
9.33

 
(20
)
 
11.81

Non-vested at January 3, 2016
917

 
$
9.23

 
104

 
$
17.08

_______________

(a)
Dividend equivalent units are issued in lieu of cash dividends for non-vested performance shares. There is no weighted average fair value associated with dividend equivalent units.

(b)
Excludes the vesting of an additional 306 shares, which resulted from the performance of market condition awards exceeding Target.

The total fair value of performance condition awards that vested in 2015, 2014 and 2013 was $1,156, $104 and $1,767, respectively. The total fair value of market condition awards that vested in 2015, 2014 and 2013 was $10,073, $6,382 and $289, respectively.

Modifications of Share-Based Awards

During 2015, 2014 and 2013, the Company modified the terms of awards granted to 25, 45 and 20 employees, respectively, in connection with its system optimization initiative and G&A realignment plan discussed in Note 5 as well as the Bakery sale discussed in Note 2. These modifications resulted in the accelerated vesting of certain stock options and performance-based awards upon termination of such employees. As a result, during 2015, the Company recognized net increases in share-based compensation of $5,977, of which $5,624, $181 and $172 was included in “Reorganization and realignment costs,” “General and administrative” and “Net income (loss) from discontinued operations,” respectively, as a result of the modifications. During 2014 and 2013, the Company recognized net increases in share-based compensation of $2,376 and $986, respectively, of which $4,472 and $1,253 was included in “Reorganization and realignment costs” respectively, with offsetting reductions to “General and administrative” of $2,096 and $267 during 2014 and 2013, respectively.

Share-Based Compensation

Total share-based compensation and the related income tax benefit recognized in the Company’s consolidated statements of operations were as follows:
 
Year Ended
 
2015
 
2014
 
2013
Stock options
$
10,081

 
$
13,692

 
$
7,223

Restricted Shares
4,834

 
4,495

 
3,907

Performance shares:
 
 
 
 
 
Performance condition awards
888

 
7,456

 
2,007

Market condition awards
1,348

 
37

 
5,279

Modifications, net
5,805

 
2,376

 
1,042

Share-based compensation (a)
22,956

 
28,056

 
19,458

Less: Income tax benefit (a)
(8,380
)
 
(10,357
)
 
(7,235
)
Share-based compensation, net of income tax benefit
$
14,576

 
$
17,699

 
$
12,223

_______________

(a)
Excludes $275, $187 and $155 of pre-tax share-based compensation and $106, $72 and $60 of related income tax benefits for 2015, 2014 and 2013, respectively, which are included in “Net income (loss) from discontinued operations.”

As of January 3, 2016, there was $18,239 of total unrecognized share-based compensation, which will be recognized over a weighted average amortization period of 2.2 years.